SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-14-241675
Filing Date
2014-06-19
Accepted
2014-06-19 06:05:08
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B4 d745764d424b4.htm 424B4 641490
2 GRAPHIC g745764g53s64.jpg GRAPHIC 18131
3 GRAPHIC g745764g68t05.jpg GRAPHIC 44621
  Complete submission text file 0001193125-14-241675.txt   729181
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-196582 | Film No.: 14929410
SIC: 2834 Pharmaceutical Preparations